Dr. Ci:Labo Co., Ltd.

TYO:4924 ISIN:JP3638700009

Based on a wealth of clinical experience and extensive knowledge, Dr. Ci:Labo continues to develop innovative skin care products. Everyday, the staff addresses and examines skin problems from every possible angle. Dr. Ci:Labo pursues simplicity in two ways. One is through simple composition, namely using natural ingredients with no unnecessary additives, to leverage the skin's natural power. The other is through an attempt to simplify the process of cleansing, toning, moisturizing, whitening, and foundation building. Dr. Ci:Labo researches and develops products produced using only natural plant extract gentle to the skin, regardless of age or skin type. The company aims to create a skin care system that not only provides a dream, but also produces tangible effects to the skin through daily use, which last one year, five years, ten years, and forever. 
 
     

View in Other Languages

News

Asian Markets Overview of January 22

🕔1/22/2010 1:30:29 PM 15901

Wall Street delivered a bad lead to Asian market today. US stocks plunged overnight as financials tumbled after President Barack Obama proposed stricter limits on financial institutions' risk-taking. Obama's plan will prevent financial institutions that own banks from investing in, owning or sponsoring a hedge fund or private equity fund.

Read Full Article
###

75,372 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 18) (Last 30 Days: 80) (Since Published: 13864) 

Company Data

    Headquarters
  • 1-1-39, Hiroo,Shibuya-ku, Tokyo 150-0012 Japan
  • Telephone
  • +81-3-6419-2500 
  • Principal Sector
  • Health & Pharm General 
  • Principal Industry
  • Consumer & Retail Products 
  • Established
  • 1999 
  • Listed
  • 2003 
  • Homepage
  • www.ci-labo.com